Sofieke Elisabeth Klamer - Epidemiology

Author Information

Sofieke Elisabeth Klamer is an esteemed researcher in the field of epidemiology and public health, with a specific focus on the epidemiology of infectious diseases. She is affiliated with Sciensano, Brussels, Belgium. Her work primarily revolves around understanding and mitigating the spread of communicable diseases, with significant contributions to COVID-19 research and surveillance.

Research Contributions

Sofieke Elisabeth Klamer has made substantial contributions to the field of epidemiology, particularly in the context of infectious diseases. Her research has been pivotal in understanding the dynamics of COVID-19, including contact tracing, laboratory-based surveillance, and the impact of economic activities on the spread of the virus. Her work also extends to the study of other infectious diseases such as genital Chlamydia trachomatis and Hepatitis E virus. Through her research, she has provided valuable insights into the prioritization of surveillance, prevention, and control of communicable diseases in Belgium.

Aliases

Sofieke Elisabeth Klamer is also known by several other names, including Sofieke E. Klamer, S. Klamer, and Sofieke Klamer.

Publication and Citation Metrics

Metric	Value
Citation Count	800
h-index	14
Paper Count	37

Publications:

COVID-19 Contact Tracing in Belgium: Main Indicators and Performance, January - September 2021.

DOI: 10.21203/rs.3.rs-1326456/v1

Year: 2022

COVID-19 contact tracing in Belgium: main indicators and performance, January – September 2021

DOI: 10.1186/s13690-022-00875-6

Year: 2022

One Year of Laboratory Based COVID-19 Surveillance System in Belgium: Main Indicators and Performance of the Laboratories

DOI: 10.21203/RS.3.RS-417041/V1

Year: 2021

Confirmed COVID-19 Cases per Economic Activity during Autumn Wave in Belgium

DOI: 10.3390/ijerph182312489

Year: 2021

Conceptual causal framework to assess the effect of SARS-CoV-2 variants on COVID-19 disease severity among hospitalized patients

DOI: 10.1186/s13690-021-00709-x

Year: 2021

Prioritisation for future surveillance, prevention and control of 98 communicable diseases in Belgium: a 2018 multi-criteria decision analysis study

DOI: 10.1186/s12889-020-09566-9

Year: 2021

Prevalence estimates of genital Chlamydia trachomatis infection in Belgium: results from two cross-sectional studies

DOI: 10.1186/s12879-021-06646-y

Year: 2021

Confirmed COVID-19 cases per economic activity during Autumn wave in Belgium

DOI: 10.1101/2021.05.31.21256946

Year: 2021

One year of laboratory-based COVID-19 surveillance system in Belgium: main indicators and performance of the laboratories (March 2020–21)

DOI: 10.1186/s13690-021-00704-2

Year: 2021

Hepatitis E virus genotype 3 subtype dependent clinical outcomes in Belgium 2010–2018

DOI: 10.1016/s0168-8278(20)32157-7

Year: 2020

What are Common Vitamin Deficiencies?

What are the Recent Advances and Future Directions?

What Challenges Exist in Genomic Epidemiology?

What are Common Study Designs in Epidemiology?

How Does MRI Contribute to Public Health?

What is the Role of Genomic Editing in Epidemiology?

What is De-identification?

Why is In Situ Important?

Does Organic Produce Reduce Pesticide Exposure?

How Do Socioeconomic Factors Influence Childhood Mortality?

Partnered Content Networks

Relevant Topics